Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Multidisciplinary Association for Psychedelic Studies (MAPS)
Recent news which mentions Multidisciplinary Association for Psychedelic Studies (MAPS)
Maps Drops Free Psychedelic Education And Artist-Curated Playlists - Start Your Journey Here
December 09, 2024
Tickers
MAPS
NEWS
Tags
Market News
Lil Yachty
Rick Doblin
From
Benzinga
Shake Up At Lykos Therapeutics After FDA Blocks Ecstasy-Based Treatment, CEO Steps Down
September 05, 2024
Tickers
CMPS
NEWS
Tags
News
Multidisciplinary Association for Psychedelic Studies (MAPS)
Management
From
Benzinga
Lykos Therapeutics Strategic Reorganization Following FDA's Decision Rejecting MDMA For PTSD Treatment
August 16, 2024
Tickers
NEWS
Tags
News
Multidisciplinary Association for Psychedelic Studies (MAPS)
Lykos Therapeutics
From
Benzinga
MDMA Therapy Papers Retracted Amid Ethical Concerns At Lykos Study Site
August 13, 2024
Tags
Cannabis
FDA
Psychedelic Research
From
Benzinga
FDA Poised To Make Historic Decision On MDMA Therapy To Treat PTSD: Here's How Things Stand
August 09, 2024
Tickers
MDMA
NEWS
Tags
Psychedelic Assisted Therapies
Psychedelics
Cannabis
From
Benzinga
Five Out Of Six Studies On MDMA Show Positive Results, Yet FDA Approval Still Faces Hurdles
August 07, 2024
Tickers
NEWS
Tags
Health Care
News
Multidisciplinary Association for Psychedelic Studies (MAPS)
From
Benzinga
Denver To Become First US City To Train First Responders In Psychedelics Crisis Intervention
March 11, 2024
Tags
Cannabis
Psychedelic Therapy
Regulations
From
Benzinga
Is Ibogaine A Safe And Effective Treatment For Addictions?
August 25, 2022
Tickers
NUMIF
Tags
Dr/ Bruno Rasmussen
General
Anvisa Agência Nacional de Vigilância Sanitária
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.